Correlation Between Pfizer and Pimco Corporate

Can any of the company-specific risk be diversified away by investing in both Pfizer and Pimco Corporate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Pimco Corporate into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Pimco Corporate Income, you can compare the effects of market volatilities on Pfizer and Pimco Corporate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Pimco Corporate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Pimco Corporate.

Diversification Opportunities for Pfizer and Pimco Corporate

-0.14

Correlation Coefficient

Pfizer  Pimco Corporate

Good diversification

The 3 months correlation between Pfizer and Pimco is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Pimco Corporate Income in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pimco Corporate Income and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Pimco Corporate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pimco Corporate Income has no effect on the direction of Pfizer i.e., Pfizer and Pimco Corporate go up and down completely randomly.

Pair Corralation between Pfizer and Pimco Corporate

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Pimco Corporate. In addition to that, Pfizer is 3.41 times more volatile than Pimco Corporate Income. It trades about -0.05 of its total potential returns per unit of risk. Pimco Corporate Income is currently generating about 0.2 per unit of volatility. If you would invest  1,309  in Pimco Corporate Income on December 27, 2024 and sell it today you would earn a total of  56.00  from holding Pimco Corporate Income or generate 4.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Pimco Corporate Income

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pimco Corporate Income

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pimco Corporate Income are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of very healthy fundamental indicators, Pimco Corporate is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Pfizer and Pimco Corporate

The main advantage of trading using opposite Pfizer and Pimco Corporate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Pimco Corporate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pimco Corporate will offset losses from the drop in Pimco Corporate's long position.

The idea behind Pfizer Inc and Pimco Corporate Income pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.